N.J. Admin. Code § 13:39-11A.10 - Responsibilities of the compounding pharmacist; reporting requirement
(a) A compounding pharmacist shall be
responsible for the ensuring that:
1.
Compounded non-sterile preparations have been properly prepared, labeled,
controlled, stored, dispensed, and distributed in accordance with the
provisions of this subchapter;
2.
All aspects of the compounding process set out in
N.J.A.C.
13:39-11A.15 are documented and that accurate
compounding records for all compounded non-sterile preparations prepared by the
pharmacy are maintained;
3.
Compounding personnel are capable of performing and qualified to perform their
assigned duties;
4. Ingredients
used in compounding have their expected identity, quality, and purity
consistent with the requirements of
N.J.A.C.
13:39-11A.12;
5. Compounded preparations are of acceptable
strength, quality, and purity, with appropriate packaging and labeling, and are
prepared in accordance with good compounding practices, official standards, and
relevant scientific data and information as set forth in USP 795, which is
incorporated herein by reference, as amended and supplemented, and which is
available for purchase at the United States Pharmacopeia website,
www.usp.org;
6. Critical processes are recorded and
validated to ensure that procedures will consistently result in the expected
qualities in the finished preparation;
7. The compounding environment is suitable
for its intended purpose;
8.
Appropriate stability evaluation is performed or is determined from the
literature for establishing reliable beyond-use dating to ensure that the
finished preparations have their expected potency, purity, quality, and
characteristics, at least until the labeled beyond-use date;
9. Compounding conditions and procedures are
in place to minimize the potential for errors;
10. Adequate procedures and records exist for
investigating and correcting failures or problems in compounding, testing, or
in the preparation itself; and
11.
The patient is advised that the product dispensed is a compounded
preparation.
(b) Any
confirmed incidents of product contamination shall be reported by the
pharmacist-in-charge to the New Jersey Board of Pharmacy within 48 hours of
becoming aware of any such incidents.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.